Section Arrow
XAIR.NASDAQ
- Beyond Air Inc.
(Financial Status)
Quotes are at least 15-min delayed:2026/08/05 23:40 EDT
Regular Hours
Last
 5.69
-0.49 (-7.93%)
Day High 
6.37 
Prev. Close
6.18 
1-M High
9.384 
Volume 
38.66K 
Bid
5.62
Ask
5.75
Day Low
5.48 
Open
6.37 
1-M Low
5.02 
Market Cap 
4.45M 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 5.59 
20-SMA 6.17 
50-SMA 7.61 
52-W High 95.6 
52-W Low 5.02 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-80.20/-1.98
Enterprise Value
27.11M
Balance Sheet
Book Value Per Share
8.50
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
7.68M
Operating Revenue Per Share
0.08
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BJDXBluejay Diagnostics Inc.1.24+0.24+24.00%-- 
BSXBoston Scientific Corp47.74-1.35-2.75%20.57PE
AMIXAutonomix Medical Inc.12.1-7.4-37.95%-- 
ADGMAdagio Medical Holdings Inc.0.739-0.061-7.63%-- 
PACBPacific Biosciences of California1.3-0.14-9.72%-- 
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Beyond Air Inc a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. Its segments are Beyond Air, Beyond Cancer, and NeuroNos. The company generates majority of revenue from Beyond Air. It has developed the Beyond Air NO generator and delivery system which it call LungFit, a novel and precise delivery system that uses NO generated from ambient air with a novel NO generator, the ionizer. Its product and technology includes LungFitPH.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.